EBITDA Margin ratio Analysis of Immuneering Corp - Deep Dive
Latest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-11159331.87
Period Ending - Dec-22
Very Poor EBITDA Margin
-15937.05
Growth
-69921.31 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Poor EBITDA Margin
0
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Poor EBITDA Margin
0
EBITDA Margin Analysis of Immuneering Corp
Ebitda Margin Ratio of Immuneering Corp with value of 0 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
Ebitda Margin Ratio of Immuneering Corp with value of 0 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
EBITDA Margin Ratio of IMRX drastically fell by -69921.31 % this year. |
EBITDA Margin Ratio with value of -382.35 was highest in Year Dec-19 in last Five Years. |
EBITDA Margin Ratio of IMRX trending down for at least three Years. |
Latest EBITDA Margin Ratio with value of -11159331.87 is lower than Average EBITDA Margin of -2235602.42 in last five years. |
Ebitda Margin of Immuneering Corp is negative because of negative EBITDA in FY ended on Dec-23. |
Other EBITDA Margin Related Info of IMRX that may interest you.
Immuneering Corp Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
IMRX | 1.47 | 1.54 | 4.55 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..EBITDA Margin Related Ratios
NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical EBITDA Margin of Immuneering Corp
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
---|---|---|---|---|---|
EBITDA Margin | -11159331.87 | -15937.05 | -1627.07 | -733.74 | -382.35 |
Change | -69921.31 % | -879.50 % | -121.75 % | -91.90 % |
FY Chart of EBITDA Margin of Immuneering Corp
Note : All Data Generated at the End of Trading Hours (EOD Data)